Federal Circuit Upholds Invalidation Of Kidney Test Patents

By Adam Lidgett · July 18, 2022, 6:20 PM EDT

The Federal Circuit on Monday refused to undo a lower court's finding that three Stanford University patents licensed to a developer of commercial tests for kidney transplant rejections were invalid, saying...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

CareDx, Inc. v. Natera, Inc.

Case Number

22-1027

Court

Appellate - Federal Circuit

Nature of Suit

830 Patent Infringement (Fed. Qst.)

Date Filed

October 08, 2021

Case Title

CareDx, Inc. v. Eurofins Viracor, Inc.

Case Number

22-1028

Court

Appellate - Federal Circuit

Nature of Suit

830 Patent Infringement (Fed. Qst.)

Date Filed

October 08, 2021

Recent Articles By Adam